HALISTER: AbbVie Patent on Humira May Be Invalid, U.S. Agency Says

AbbVie Patent on Humira May Be Invalid, U.S. Agency Says

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
ABBV US (AbbVie Inc)
4523 JP (Eisai Co Ltd)
CHRS US (Coherus Biosciences Inc)

People
Dennis Lanfear (Coherus Biosciences Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283